Trial intelligence / Profile preview

Sativex for Cognitive Function and Mood in MS Spasticity

NCT01964547Phase 4Completed

Sponsor
Jazz Pharmaceuticals plc
Start
Jan 2012
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cannabidiol in spasticity, sponsored by Jazz Pharmaceuticals plc. Started Jan 2012; status: completed.

02

Drugs

cannabidiol
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT01964547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01964547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call